·       Founder of AUM Biosciences and Chairman of AUM’s Board of Directors.

·       Extensive experience in structuring and managing global deals worth over US$4 billion in drug development with major pharmaceuticals, and biotech companies.

·       Previously held senior business development and management roles at IQVIA, EPS International and ICON and many more reputed global enterprises

·       Achieved 145M USD PE deal with a major pharmaceutical company that resulted in achieving POC for 3 major oncology drugs currently on the market with peak sales of over 4B USD combined along with other founders

·       Within 12 months of inception, successfully lead AUM Bioscience transition from a pre-clinical to a clinical stage company and developed a portfolio of transformative cancer medicines

·       Awarded the 2019 Asia-Pacific Biotech Entrepreneurial Company of The Year by Frost and Sullivan.

·       Nominated as a Young Global Leader by the World Economic Forum for Class of 2021.

·       Key Opinion Leader to Korean Health Industry Development Institute

·       Master’s Degree in Pharmaceutical Sciences from Kingston University with research focus in Aromatase inhibitors in Breast cancer.

·       Bachelor of Pharmacy from University of Mumbai